Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Research Center for Psychiatry and Behavioral Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Neurophysiol Clin. 2021 Dec;51(6):524-532. doi: 10.1016/j.neucli.2021.10.001. Epub 2021 Nov 8.
Brainstem auditory evoked response (BAER) is a non-invasive modality that can be used to investigate brainstem neuronal function in movement disorders. The differentiation between drug-induced parkinsonism (DIP) and Parkinson's disease (PD) can be very challenging. Although PD and DIP to some extent display similar clinical symptoms, the underlying pathophysiologic mechanisms are entirely different. Given these differences in pathogenesis, and the diagnostic utility of BAER for detecting brainstem function, BAER may help to distinguish between PD and DIP. This study aimed to assess the accuracy and predictive values of BAER parameters in differentiating DIP from PD.
We prospectively studied143 participants classified within three groups, including 50 controls, 57 PD, and 36 DIP. BAER was performed on all patients in the study. Patients in the DIP group were followed up for at least one year after discontinuation of the causative drug and examined for final diagnosis. We compared BAER latencies of the three groups and measured sensitivity, specificity, predictive values, likelihood ratios, and accuracy of BAER in diagnosing DIP.
Waves V, I-V, and III-V latencies were significantly prolonged among the PD patients compared to the DIP and the control group; however, there were no significant differences in BAER latencies between the DIP and the control group. Waves V and I-V latencies revealed the highest accuracy (86% and 79%, respectively) in distinguishing DIP from PD with high negative predictive value(89% and 83%, respectively) as well as a high negative likelihood ratio (0.2and 0.3, respectively).
This study showed that waves V and I-V latencies are significantly prolonged in PD patients compared to those with DIP, consistent with the proposed mechanisms of neurodegeneration in PD, particularly in the midbrain and pons. Consequently, BAER could be used as a useful diagnostic tool for differentiating DIP from PD.
脑干听觉诱发电位(BAER)是一种非侵入性的方法,可用于研究运动障碍中的脑干神经元功能。区分药物诱导的帕金森病(DIP)和帕金森病(PD)可能非常具有挑战性。虽然 PD 和 DIP 在某种程度上显示出相似的临床症状,但潜在的病理生理机制却完全不同。鉴于发病机制的这些差异,以及 BAER 检测脑干功能的诊断效用,BAER 可能有助于区分 PD 和 DIP。本研究旨在评估 BAER 参数在区分 DIP 和 PD 中的准确性和预测值。
我们前瞻性地研究了 143 名参与者,分为三组,包括 50 名对照组、57 名 PD 患者和 36 名 DIP 患者。对所有研究患者进行 BAER 检查。DIP 组患者在停用致病药物后至少随访一年,并进行最终诊断检查。我们比较了三组的 BAER 潜伏期,并测量了 BAER 诊断 DIP 的敏感性、特异性、预测值、似然比和准确性。
与 DIP 和对照组相比,PD 患者的波 V、I-V 和 III-V 潜伏期明显延长;然而,DIP 和对照组之间的 BAER 潜伏期没有显著差异。波 V 和 I-V 潜伏期在区分 DIP 和 PD 方面具有最高的准确性(分别为 86%和 79%),具有较高的阴性预测值(分别为 89%和 83%)和较高的阴性似然比(分别为 0.2 和 0.3)。
本研究表明,与 DIP 患者相比,PD 患者的波 V 和 I-V 潜伏期明显延长,与 PD 中神经退行性变的提出机制一致,特别是在中脑和脑桥。因此,BAER 可作为区分 DIP 和 PD 的有用诊断工具。